Superluminal Medicines
PrivateLast Round
Strategic
Aug 14, 2025
Total Funding Raised
$153M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Superluminal Medicines is a biotechnology company that leverages generative biology, machine learning, and structural biology to accelerate the discovery and development of small molecule therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Superluminal Medicines Comparables
Compare Superluminal Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Molecular AI | 83% | |
| Fathom Therapeutics | 83% | |
| Terray | 81% | |
Superluminal Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 14, 2025 | ||||
| Series A | Sep 9, 2024 | ||||
| Seed | Aug 28, 2023 |
Superluminal Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Seed, Series A |
| Gaingels | Seed, Series A |
| Catalio Capital Management | Series A |
| NVentures | Series A |
| Cooley | Series A |
| Insight Partners | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Grew 28% QoQ, from 40 to 51 employees.
- Aug 14, 2025
Eli Lilly and Company led the strategic round.
Superluminal Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Superluminal Medicines's valuation, stock price, and market status.